Consultation: Regulatory options to allow references to the TGA in therapeutic goods advertising

Closed 7 Nov 2022

Opened 26 Sep 2022


The Therapeutic Goods Administration (TGA) is considering regulatory options to allow advertisers, including product sponsors, to make references to the TGA in advertising (including on product labels).

We are seeking feedback on:

  • whether references to the TGA should be allowed in therapeutic goods advertising
  • the class or classes of therapeutic goods, if any, that should be allowed to refer to the TGA
  • options for what a reference to the TGA could look like
  • options for how an authorised reference to TGA may be used in advertising
  • whether references to TGA should be optional or mandatory for advertisers.

Why your views matter

Currently advertisers are prohibited from suggesting or implying that a product has been approved or endorsed by a government agency, such as the TGA, without authorisation. 

We are seeking feedback on whether allowing references to the TGA in therapeutic goods advertising may support consumers to make better informed health decisions by more clearly identifying products that have met the regulatory requirements and are being lawfully advertised and sold.

What happens next

Feedback collated during this consultation process will assist the TGA in determining options that are taken forward for further consideration.


  • Anyone from any background


  • Legislation
  • Regulatory policy
  • Non-prescription medicines